<DOC>
	<DOCNO>NCT00875342</DOCNO>
	<brief_summary>This study propose evaluate effect D-cycloserine ( DCS ) combine cognitive-behavioral treatment exposure therapy sample patient develop posttraumatic stress disorder ( PTSD ) consequence various trauma ( e.g. , motor vehicle accident , burn injury , combat , World Trade Center attack , etc. ) . In addition , study hope determine whether common human genetic single nucleotide polymorphism ( SNP ) growth factor , brain derive neurotrophic factor , BDNF SNP ( Val66Met ) , predict treatment response PTSD . Patients live area geographically proximal Weill-Cornell Medical Center New York City campus receive cognitive behavioral therapy use telemedicine ( videoconferencing technology ) . Overall , study aim 1 ) determine subject administer DCS show significantly large decrease symptom PTSD compare administer placebo , 2 ) determine subject administer DCS show decrease PTSD symptomatology significantly earlier ( measured week ) administer placebo , 3 ) determine difference symptomatology evident 6-month follow-up indicate long-term difference group , 4 ) determine BDNF SNP predict treatment response , 5 ) determine feasible acceptable provide imaginal exposure ( IE ) therapy PTSD use videoconferencing technology .</brief_summary>
	<brief_title>Imaginal Exposure &amp; D-Cycloserine ( DCS ) Posttraumatic Stress Disorder ( PTSD )</brief_title>
	<detailed_description>Following initial assessment evaluate eligibility study , eligible participant randomly assign one two treatment group : imaginal exposure ( IE ) plus DCS ( 100mg ) IE plus placebo ( sugar pill ) . DCS broad spectrum antibiotic recently implicate cognitive enhancer may enhance treatment occurs . The participant , assessor treat clinician blind pill participant receiving . The dose medication need take day therapy session exposure occur ( approximately 9 time ) . Both group treat standardized cognitive-behavioral exposure therapy protocol utilize gold-standard treatment , consist 12-14 weekly individual ( one-on-one ) session highly qualify clinical psychologist . Treatment intervention include imaginal exposure , graduate vivo exposure , psycho-education , relaxation training , behavioral activation , cognitive restructuring . Assessments occur prior treatment , follow session 3 , 6 10 , follow completion treatment , 6 month conclusion treatment . In addition , participant genotyped BDNF SNP ( Val66Met ) use non-invasive saliva sample .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>Cycloserine</mesh_term>
	<criteria>1 . Englishspeaking adult 2 . Age 1870 3 . Survivor variety trauma ( e.g. , motor vehicle accident , burn others injury , combat , World Trade Center attack , etc . ) 4 . Diagnosed PTSD 5 . In good health . For person chronic injuries/conditions related accident , `` good health '' define injury state stabilization able attend weekly outpatient session . 1 . Current organic mental disorder 2 . Schizophrenia symptoms psychosis/delusions 3 . Bipolar disorder 4 . Current substance abuse dependence 5 . Active suicidal/homicidal ideation , intent , plan 6 . Use pacemaker 7 . Significant health impairment , include renal disease 8 . Taking oral anticoagulant medication , ethionamide ( TrecatorSC ) , isoniazid ( INH ) , antidepressant medication 9 . Hypersensitivity cycloserine 10 . History seizures 11 . Pregnant currently try conceive , breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Traumatic Event</keyword>
	<keyword>Trauma Survivor</keyword>
	<keyword>Exposure Therapy</keyword>
	<keyword>PTSD DCS</keyword>
	<keyword>Telemedicine</keyword>
	<keyword>Telepsychiatry</keyword>
	<keyword>Telemental health</keyword>
</DOC>